Diaphragmatic Myofascial Release in Gastroesophageal Reflux Disease

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-10-05

Study Completion Date

2018-03-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is a double blinded randomized clinical trial with two arms which aims to study the effects of diaphragmatic myofascial release in patients with gastroesophageal reflux disease (GERD).

GERD has become in the last decades a common disease at the occidental world affecting between 10 to 15% of this population. That implies a high socio-health cost and the decline of the quality of life of those patients.

The diaphragm muscle surrounds the lower esophageal sphincter, and helps to prevent gastroesophageal reflux. If one or both structures become incompetent, it may appear GERD. Until the moment, the treatment for GERD begins by lifestyle modification, and if it fails, the treatment becomes medical and, in selected cases, surgical.

It exists some studies that have demonstrate that diaphragmatic breathing training can have a positive effect in GERD and the need of drug usage. But until the moment, the effects of a myofascial release of the diaphragm haven't been explored on these patients.

Thirty patients with GERD referred from different hospitals of Valencia will be randomized into two groups:

* Intervention with myofascial release for the diaphragm
* Sham treatment group which is going to receive the same number of session treatments with the same manual techniques, but without the myofascial stimulus The protocol that will be applied consists of 4 identical sessions of myofascial release techniques aimed to normalize the myofascial tension of the diaphragmatic muscle. These sessions will be distributed in two weeks.

The study focuses on the analysis of the following variables:

* Frequency and intensity of the symptoms of GERD: Reflux Disease Questionnaire (RDQ)
* Specific quality of life for gastrointestinal disease: Gastrointestinal Quality of life Index (GIQLI)
* Drug usage: weekly milligrams usage of proton pomp inhibitors (PPI) The results of these pre-intervention and post-intervention variables will be compared between the two groups at baseline (first session), at week 3 and at week 6.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Manual Therapy and Gastroesophageal Reflux Disease in Patients With Hiatal Hernia

NCT05283447

Gastroesophageal Reflux

COMPLETED NA

Effect of Manual Diaphragmatic Activation on Diaphragm Function in Patients With Gastroesophageal Reflux Disease

NCT06268548

Diaphragm Dysfunction

RECRUITING NA

Response Surface Pathway Design With Two Interventional- and One Response Variable in Estimating Minimum Efficacy Dose

NCT03568825

GERD

COMPLETED NA

Comparison of Two Therapies for Upper Esophageal Sphincter (UES) Dysphagia

NCT00059670

Deglutition Disorders

COMPLETED NA

The Efficacy of Neiguan (P6 Point) Acupressure in Patients With Gastroesophageal Reflux Disease (GERD)

NCT02255071

Gastroesophageal Reflux Disease

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Gastroesophageal Reflux Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

double blinded randomized clinical trial

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Diaphragmatic myofascial release

Subjects in this arm will receive different myofascial release techniques aimed to normalize the myofascial tension of the diaphragmatic muscle

Group Type EXPERIMENTAL

Diaphragmatic myofascial release

Intervention Type OTHER

Subjects in this arm will receive different myofascial release techniques aimed to normalize the myofascial tension of the diaphragmatic muscle

Sham myofascial release

Subjects in this arm will receive the same manual techniques of the diaphragmatic myofascial release group, but without the myofascial stimulus

Group Type SHAM_COMPARATOR

Sham myofascial release

Intervention Type OTHER

Subjects in this arm will receive the same manual techniques of the diaphragmatic myofascial release group, but without the myofascial stimulus

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Diaphragmatic myofascial release

Subjects in this arm will receive different myofascial release techniques aimed to normalize the myofascial tension of the diaphragmatic muscle

Intervention Type OTHER

Sham myofascial release

Subjects in this arm will receive the same manual techniques of the diaphragmatic myofascial release group, but without the myofascial stimulus

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with the diagnostic of GERD

Exclusion Criteria

* hiatal hernia \>2 cm
* previous operation at the LES
* actual erosive esophagitis
* Congenital or acquired immune disorders.
* Allergic status of any kind.
* Systemic diseases (rheumatic, infectious conditions, febrile state, vascular alterations, endocrine including diabetes, metabolic and neoplastic).
* Leukemia.
* Severe psychiatric disorders.
* Neuromuscular or neurological injuries.
* Aneurysms.
* Abdominal or spine surgery.
* Vertebral fractures.
* Osteoporosis (advanced stage).
* Acute lesions of soft tissues or in an inflammatory state.
* Open wounds.
* Pregnancy.
* Intrauterine device.
* Patients with corticosteroid therapy.
* Hemophilia or treatment with anticoagulant therapy.
* Hypersensitivity of the skin or dermatological diseases in the trunk that impossibilities the application of the techniques.
* Rejection of manual contact.
* Non-Spanish speaking patients.
* Patients who have previously received some treatment of myofascial release.

Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No